Over 20 years in the fight against AMR 

Antibiotic resistance is one of the greatest threats to global health today, impacting patients and communities alike.

Annually, 5 million deaths are associated with AMR-related infections, including 1.3 million directly caused by antimicrobial resistance.

Since 2002, CHROMagar has been committed in the fight against antimicrobial resistance, starting with CHROMagar™ MRSA, our 1st medium for detecting resistant bacteria.

For the past two decades, we’ve continuously providing reliable tools to help healthcare professionals tackle this global challenge.

Through rapid and precise detection of antibiotic-resistant bacteria, our chromogenic culture media enable healthcare teams to:

Act fast: Early detection allows for timely and targeted interventions.

Optimize treatment: By identifying resistant strains, healthcare providers can avoid ineffective antibiotics and reduce the risk of further resistance.

Strengthen infection control: Enhanced surveillance through screening helps monitor and control the spread of resistant bacteria, both in hospitals and in the community.

At CHROMagar, we are committed to equipping laboratories worldwide with advanced, reliable tools that support safer patient care, more effective treatment, and stronger public health protection.

 

Together, we are contributing to the global fight against antibiotic resistance, working towards a healthier, safer future for all.